ʻO ka ʻokoʻa nui ma waena o Victoza ʻo ka pau ʻole o nā analogues i ka mākena pharmacological, e pili ana i ka kulekele kumukūʻai o kēlā lāʻau.
Pono ka lāʻau lapaʻau e hoʻemi me ka hoʻohaʻahaʻa i ka glucose o ke koko, akā ua loaʻa iā ia kona noi e like me ka lāʻau lapaʻau e hoʻomaʻamaʻa i ke kaumaha nui loa.
He aha ka paʻakikī paʻakikī o nā kulekele?
ʻO ka mellitus non-insulin-non-kiʻekiʻe he maʻi endocrine i hoʻohiki ai nā mea i loko o ke kino i ka insulin i hana ʻia e ka pancreas.
Ma muli o kēia kaʻina hana, nalowale nā sela i ko lākou ʻike i ka hormone, ʻaʻole hiki i ka glucose ke komo i loko o nā ʻāpana, hōʻiliʻili i ke kino. I ka huli ʻana, ʻike ʻia kahi piʻi o nā kiʻekiʻe o ka insulin, ʻoiai ʻo ka pancreas e hoʻomaka nei e hana i kahi nui o kēia hormone i ka nui o ka nui.
I ka wā o ka hoʻomohalaʻana o ke kaʻina pili, hiki i ka hōʻino i nā hana kūloko āpau i ke kino, nui nā kino o loko a me nā ʻōnaehana e hōʻeha.
Hoʻokumu ʻia ka mālama ʻana o nā maʻi hou i nā kulekele penei:
- Ke hoʻokō nei me nā meaʻai. ʻO ke koho kūpono o nā menus a me nā meaʻai i hoʻohana ʻia, ʻaʻole wale ia e kōkua i ka hōʻemi ʻana i nā pae glucose, akā kōkua pū nō hoʻi i ke kaumaha. E like me ʻoe e ʻike ai, ʻo kekahi o nā kumu i ka hoʻomohala ʻana o ka non-diabetes-mellitus e hoʻohana nei i ka momona.
- He hopena maikaʻi ka lāʻau kūlohelohe i ka maʻamau o ke kaila o ke koko. ʻO kekahi manawa lawa ia e alakaʻi ai i kahi hana hana, e hele i nā lā i kēlā me kēia lā i ka ea hou me ka meaʻai kūpono, i loaʻa ai ka mea maʻi.
- ʻO ka lāʻau lapaʻau. Ke lawe hou nei i ke kō i ka hana maʻamau e kōkua i nā lāʻau kūpono i ʻōlelo ʻia e kāu kauka.
I kēia manawa, ʻo ka hoʻohana ʻana o nā mellitus e hana ʻole i ka inika-insulin mellitus ka hoʻohana ʻana o kekahi o kēia o nā hui o nā mea lapaʻau:
- nā lāʻau lapaʻau e pili ana i ka sulfonylurea. ʻO ka hopena pharmacological ka hoʻoulu ʻana i ka mea huna o ka insulin endogenous;
- nā lāʻau lapaʻau i komo pū me ka hui o nā biguanides. Hoʻohana ʻia kā lākou hopena i ka hōʻemi ʻana i ka pono no ka huna ʻana o ka insulin;
- nā lāʻau lapaʻau e ʻike i nā thiazolidinol e kōkua i ka hoʻemi ʻana i ke kō koko koko a he hopena maikaʻi i ka maʻamau o ka maikaʻi lipid;
- hoʻohui.
Inā ʻaʻole i lawe mai nā lāʻau i luna aʻe e hoʻohaʻahaʻa i ke kō koko koko maikaʻi i ka hopena maikaʻi loa, hiki i ka hoʻohana 'ana i ka insulin.
ʻO nā hopena lāʻau lapaʻau nui o ka lāʻau
ʻO ka laʻau Victoza, ma ke ʻano he kānāwai, ua kuhikuhi ʻia i nā mea maʻi me ka hoʻomau ʻana i ka maʻi mellitus non-insulin-dependence, i mea pili i ka lāʻau lapaʻau kōkua. Pono ke ʻano me kahi mea lapaʻau me ka hoʻohana ʻana i kēlā lāʻau lapaʻau me ka lāʻau kūikawā a me ke ʻano hoʻoikaika kino kino. Aia wale i kēia hihia, hiki iā ʻoe ke hoʻokō i ka hopena kiʻekiʻe loa mai ka hoʻohana ʻana i ka lāʻau lapaʻau.
ʻO ka lāʻau lapaʻau Victoza e hana ʻia e ka mea hana ma ka ʻano o ka hoʻonā no ka injutaneous injection. I nā papa a me nā ʻano lāʻau lapaʻau, ʻaʻole i hōʻike ʻia ka lāʻau i kēia lā.
ʻO ka lāʻau lapaʻau ʻo Victoza kahi mea hoʻohālikelike o ka peptide-like like o ka glucagon-ʻo kahi mea i hana ʻia e ka hana biotechnological, a me kanaiwa kanaiwaʻumiku mau kauka me ia. Hoʻopili ka mea i kekahi mau mea hoʻopiʻi e nānā ʻia ana e ka puke i hana ʻia e ke kino. I ka huli ʻana, he mea hoʻopuka ka hormone hoʻonā i ka hoʻoulu ʻana i ka hana o ka insulin inā he piʻi ka glucose o ke koko.
Hiki pū ka hopena o ka lāʻau i ka hōʻemi ʻana i ka hana o ka insulin inā ʻike ʻia kahi kūlana hypoglycemia. Pēlā, e kau ʻia ana ka nui o ka paona a me ka normalization, ka nui o ka momona momona e emi iho ana, a ua nui ka momona momona.
Loaʻa ka lāʻau lapaʻu e like me ka syringe pen Victoza volume o ʻekolu mau mililger. ʻO ka mea hana nui i ka lāʻau lapaʻau ka liraglutide. Hoʻokomo ʻia ka lāʻau i loko o ʻewalu a i ʻumikūmālua hola, a ma hope o kēia manawa wale nō ke nānā ʻia kona kiʻekiʻe o ke koko.
Kuhi ʻia ka syringe penu ʻo Victoza i kā ka pahu pahu pepa kūikawā ma ka nui o hoʻokahi, ʻelua a ʻekolu paha mau inikini. Eia kekahi, loaʻa i nā ʻōlelo kikoʻī kikoʻī no ka hoʻohana ʻana i kahi huahana lapaʻau me kēia ʻike.
- Ke alakaʻi nei kahi papa hana e pili ana i ke ala a me kahi e hakakā ai ʻo Victoza.
- No nā ʻano hana.
- ʻO ka hoʻohana kūpono ʻana i ka pono.
- Nā hopena ʻaoʻao a me nā contraindications.
Hoʻonohonoho ʻia ka pōpō me nā pulima i loko o kahi pahu pahu aniani kūikawā, aia hoʻi i kahi penikala syringe hoʻohana hou ʻia. Ua lawa kēlā me nā syringe no nā kanakolukū o 0.6 mg. Inā koho ke kauka i nā hala nui i ka mea maʻi, ua hoʻemi ʻia ka nui o nā inikini. Hana maʻalahi ka injection, ka mea nui e kiʻi i kekahi mau akamai e hoʻokomo i ka pono ma lalo o ka ʻili.
ʻO nā mea nui nui no ka inikini me ka diabetes mellitus type 2 e pili ana i kēia lāʻau lapaʻau e like me kēia:
- e like me ka lāʻau nuiꓼ
- a me nā lāʻau lapaʻau ʻē aʻe - Metformin, Glibenclamide, Dibetolongол
- i ka hoʻohana ʻana me ka ʻenehana insulin.
Eia kekahi, hiki ke kuhikuhi ʻia i kahi lāʻau lapaʻau i nā mea maʻi me ka maʻi maʻi i ka lālama no ka hōʻemi ʻana i ka paona. Hōʻike ka loiloi o nā maʻi maʻi Victoza i ka wā e lawe ai i ka lāʻau lapaʻau, ke nānā nei ka hoʻokaʻawale o ka mea momona, e hoʻāla ka pae o ka glucose i ke koko.
Eia kekahi, ʻo ka injection maʻamau no ka mahina e kōkua e hoʻomaʻamaʻa i ka nui o nā triglycerides.
Nā ʻōkuhi no ka hoʻohana ʻana i ka lāʻau lapaʻau
ʻO nā ʻōlelo a Victoza no ka hoʻohana ʻana e pono e hoʻokō ʻia ka hoʻomaka ʻana me nā ʻoi loa o ka lāʻau. Pēlā, e hoʻolako ʻia ka mana metabolic pono.
I ka wā o ka lawe ʻana i ka lāʻau lapaʻau, pono e ʻike pinepine ka mea maʻi i ka pae o ka glucose i loko o ke koko. ʻO ke ʻano o ka lāʻau lapaʻau, ʻo ia hoʻi ka nui o nā doses i hoʻokomo ʻia i ka wailana, ua hoʻoholo ʻia e ke kauka komo ʻana. I kēia hihia, ʻaʻole pāpā ʻia ka lāʻau lapaʻau ponoʻī.
Hoʻohana ʻia ka lāʻau Viktoza i hoʻokahi manawa i ka lā, ʻoiai ʻo ka hana o ka mea kūlohelohe maulalakela ka hoʻomaka i ka wā ma hope o kekahi manawa.
Pono e mālama ʻia kahi maʻi me Victoza ma lalo o ka ʻili i loko o kahi o nā wahi kūpono loa:
- Pahu.
- ʻEha.
- Aapoʻi
I kēia hihia, ʻaʻole i hilinaʻi ka maʻi huakaʻi i ka maʻi ʻaʻai ʻokoʻa. E like me ke kauoha ʻana, ua manaʻo ʻia ʻo ia ka mea kūpono e nānā i ka manawa like i waena o nā inikini. Pono e hoʻomanaʻo ʻia ʻaʻole ka ʻae ʻia ka lāʻau Viktoza e komo i ka intravenously a i ʻole intramuscularly.
ʻO ka nui o nā ʻōkuhi i ʻōlelo ʻia i kau ʻia ma ka paʻakikī o ka ʻōpū o ka maʻi a me nā hiʻohiʻona pilikino o ka mea maʻi. I nā hoʻomaka mua o ka lāʻau lapaʻau, ʻoi ʻia ia e hoʻokomo i hoʻokahi manawa i kēlā lā, ʻo ia ʻo 0.6 mg o ka liraglutide. ʻAʻole i hala ma mua o kahi hebedoma ma hope o ka hoʻomaka ʻana o ka hana lapaʻau, ʻae ʻia kahi piʻi o nā dosis a hiki i 1,2 mg o ka lāʻau lapaʻau i kēlā me kēia lā. ʻO kēlā me kēia hoʻonui i nā dosages e hele mai me kahi kekelē o ʻehiku mau lā.
ʻO ka nui loa o ka liraglutide i lawelawe ʻia ʻaʻole eʻoi aku ma mua o 1,8 mg.
ʻO ka pinepine ma ka paʻakikī paʻakikī, hoʻohana ʻia kahi lāʻau e hui pū me ka Metformin a i ʻole nā lāʻau lapaʻau haʻahaʻa. I kēia hihia, ua hoʻoholo ʻia nā mea hoʻohālikelike o nā lāʻau lapaʻau e nā kauka ʻea.
Wahi a ke ʻano lapaʻau, ma ka mālama ʻana i nā patology i ka poʻeʻelemakule, ʻaʻole i ʻokoʻa nā ka nui o ka lawelawe ʻana i ka lāʻau i nā mea i hōʻike ʻia ma luna nei.
ʻO nā loiloi e pili ana i ka Victoza o nā loea lapaʻau e hoʻoheheʻe i ka ʻoiaʻiʻo no ke hoʻohana ʻana i ka lāʻau lapaʻau e lawe wale ʻia e like me ke kuhikuhi ʻana e ke kauka. I kēia hihia, hiki iā ʻoe ke pale i ke ʻano o nā hopena o nā ʻaoʻao a koho i ke ʻano kūpono.
ʻOi aku ka maikaʻi ma ka mālama ʻana i ka lāʻau i loko o ka friji i ke mahana o ʻelua a ʻewalu degere.
Hoʻohana ʻia ka haʻalele ʻana i ka lāʻau lapaʻau i nā wahi i ka komo ʻole ʻana o ka lā, i ʻike ʻia ʻaʻole eʻoi aku ka wela ma mua o ke kanakolu.
He aha nā contraindications no ka hoʻohana ʻana?
E like me nā lāʻau ʻē aʻe, he nui nā contraindications no Victoza no ka hoʻohana ʻana.
Hōʻike ʻia nā contraindications i loaʻa i nā kuhikuhi i hoʻohana ʻia no ka lāʻau lapaʻau.
Me ka papa lapaʻau e pono ai nā kipa me Victoza, pono e noʻonoʻo pono i nā contraindications āpau i kāna hoʻohana ʻana.
ʻAʻole pono e hoʻohana ʻo Liraglutide i kēia mau pilikia:
- hypersensitivity i hoʻokahi a keu aʻe paha o nā lāʻau
- nā mea maʻi me ka maʻi diabetes-type type
- inā he maʻi maʻi maʻi ketoacidosisꓼ
- nā pilikia me ka hana pūpū maʻamau, nā pathologies organ path severe
- i ka hihia o ka pilikia me ka hana o nā ate the
- ma ka hihia o ka hoʻopiha ʻana o ka ʻōnaehana genitourinary
- inā loaʻa nā maʻi o nā kino o ka ʻōnaehana cardiovascular, ka huhū o ka naʻau
- ka hoʻomohala ʻana o nā kaʻina o ka ʻaina i loko o ka ʻawaʻawa, a me nā maʻi ʻē aʻe o nā ʻāpana o ka gastrointestinal tract (me nā pū kekahi o ka ʻōpū) ꓼ
- nā keiki ma lalo o nā makahiki he ʻumikumamāwalu mau makahiki a me nā maʻi ma hope o kanahikukūmālima mau makahiki
- nā kaikamahine i ka wā hāpai a me ka lactation.
Ua hōʻike ʻia nā noiʻi noiʻi i ka contraindicated no nā wahine e lawe i ka lāʻau lapaʻau i ka wā hāpai. Aia ka hopena kiʻekiʻe ma ka hopena maikaʻiʻole o ka hana ikaika ma ke kūkulu ʻana i ke kōpala a me kona ola. Pono ʻoe e hōʻole ma ka hoʻohana ʻana i ka lāʻau lapaʻau i ka wā o ka hoʻolālā o ke keiki hānau ʻole. ʻO ka manawa o ka lactation, ke ʻōlelo nei nā kauka ʻaʻole ʻo Viktoza i loko o ka umauma umauma. I kēia hihia, ʻoiai ʻo ka umauma umauma, ʻaʻole ia e noi ʻia e lawe i lāʻau lapaʻau me ia.
No ka mea e hoʻohana ʻia ka lāʻau lapaʻau e mālama i ka maʻi diabetes a he hopena kūpono i ka maʻamau o ke kaupaona ʻana o ka nui o ka nui i nā poʻe maʻi o kēia ʻano, ke hoʻohana nei kekahi poʻe olakino ia e ʻoi no ka nalo ʻana o ke kaumaha.
Hoʻomaopopo nā kauka i ke kāohi ʻana i ka hoʻohana ʻana i kēlā me kēia hana palupalu, ʻoiai aia ka pilikia nui o ka hoʻomohala ʻana i ka maʻi thyroid inā lawe ʻia ka lāʻau lapaʻau i nā kānaka olakino
He aha nā hopena maikaʻi ʻole e hiki mai?
Ke hoʻohana ʻia i ka lāʻau lapaʻau, hiki i nā hopena hopena.
ʻO ka hōʻa ʻole i ka ʻōlelo a ke kauka e hele ana, me ka haʻalele ʻana i ka ʻike i hōʻike ʻia i nā ʻōlelo kuhikuhi no ka hoʻohana ʻana i ka lāʻau lapaʻau, hiki ke alakaʻi i nā hopena ʻaoʻao.
Hoʻomaʻamaʻa pinepine ʻia, ʻike ʻia kahi ʻano maikaʻi ʻole i nā papa mua o kahi papa hana therapeutic.
ʻO nā mea nui ka hopena e kū mai ma muli o ka lawe ʻana i ka lāʻau lapaʻau ka mea e hōʻike ai i ka hopena o ka hopena:
- ʻO ka paleʻana i nā kaʻina metabolic o ka meaʻaiʻai. ʻO nā mea nui he nausea, luaʻi, hōʻeha a i ʻole constipation, ʻeha i loko o ka ʻōpū, hoʻopau piha i ka ʻono. I nā hanana hou aʻe, ʻike ʻia ka dehydration.
- Hiki i ka ʻōnaehana sentral ke hāʻawi i nā hōʻailona ma ke ʻano o nā poʻo o ke poʻo hōʻeha.
- ʻO nā hopena ʻino loa no nā kino o ka gastrointestinal pinepine e loaʻa pinepine, e like me ka hoʻomohala a me ka hoʻonāukiuki paha i ka gastritis, gastroesophageal reflux, belching, bloating a hoʻonui hou i ka hoʻokumu ʻana i ka mīkini. Kuhi loa, hoʻonele nā poʻe maʻi i ka hoʻomohala ʻana o ka maʻi pancreatitis maʻa.
- Hiki i nā pilikia mai ke ʻano ke pale aku i ka hopena me nā hopena anaphylactic.
- I ke ʻano o nā kaʻina kūpono o ka ʻōpū hanu o luna.
- ʻO nā hopena maikaʻiʻole mai ka hoʻonāukiuki.
- ʻO ka momona nui o ke kino a me ka olakino maikaʻi
- Ma ka ʻāpana o ka ʻōnaehana genitourinary, ʻike nā hopena ʻokoʻa iā lākou iho me ka hiki ʻole o ka renal nodula, nele i ka maʻamau o ka pēpē maʻamau
- ʻO nā pilikia me ka ʻili. I ka hapanui pinepine, hōʻike ʻia nā ʻano like ʻole i ke ʻano o nā rashes ma ka ʻili, urticaria, a me ka ʻeha.
I ke ʻano o ka hypoglycemia, ke hōʻike nei ka hopena i ka maʻi ma nā mea maʻi. Hiki ke ʻano he hopena like i ka wā ʻaʻole i mālama pono ʻia ka dosage, ʻoiai me ka hoʻohui pū ʻana me nā lāʻau lapaʻau haʻahaʻa. I ka lāʻau lapaʻau, ʻike ʻia ka hypoglycemia koʻikoʻi i ka diabetes mellitus i ka wā e hui pū ai i ka Viktoza me nā lāʻau lapaʻau mai ka hui o nā derivatives o ka sulfonylurea.
Eia kekahi, ʻo ka lawe ʻana i ka lāʻau lapaʻau i kekahi mau hihia e hui pū ʻia me ka hoʻomohala ʻana i nā hopena alerē, e hōʻike ana iā lākou iho i ke ʻano o ka urticaria, ʻāʻī, paʻakikī ka hanu, a me ka hoʻonui pinepine ʻana i nā ʻoka o nā puʻuwai.
Me ka overdose o ka lāʻau lapaʻau ma mua o ke kanaha mau manawa, ua hōʻole ʻia ia i ke ʻano o ka puha a me ka luaʻi nui. I ka manawa like, ʻaʻole hāʻule ka pae o ka glucose i ke koko i nā pae koʻikoʻi.
I ka hihia o ka overdose, ua ʻōlelo ʻia e hahai i nā ʻōlelo manaʻo o ke kauka e hele ana a hoʻomā ma kahi o ka hana lapaʻau maʻi lapaʻau.
Hiki paha ke hoʻololi iā Viktoza i kahi huahana me nā huahana like?
I kēia lā, ʻaʻole ke kālepa o ka lāʻau lapaʻau i nā mea kikowaena piha o ka lāʻau Viktoza.
ʻO ke kumukūʻai o ia lāʻau lapaʻau, ʻo ka mea mua loa, ke hilinaʻi nei i ka helu o nā syringe penikala i ka waihona.
Oe ke kuai i ka lāʻau lapaʻau i loko o nā lāʻau lapaʻau o ke kūlanakauhale mai 7 a 11.2 tausani mau rubles.
Hoʻohālikelike ʻia nā lāʻau lapaʻau e like me kā lākou hopena o ka lāʻau lapaʻau, akā me nā mea kanu e ae nei:
- ʻO ka Novonorm kahi lāʻau lapaʻau i loaʻa ka hopena me ke kōpaʻa i ke kō. ʻO ka mea hana o kēlā lāʻau lapaʻau ka Kelemānia. ʻO ka mea hana kumu nui ka repaglinide o ka waiwai. Hoʻohana pinepine ia no ka mellitus non-insulin-hilinaʻi, ʻo ia ke ʻano hana nui a i ʻole ke hui pū ʻana me ka metformin a i ʻole thiazolidinedione. ʻO ke kumukūʻai o ka lāʻau lapaʻau, hilinaʻi ʻia ma ka dosage, hoʻololi ʻia mai ka 170 a 230 mau rubles.
- ʻO Baeta kahi lāʻau lapaʻau i kuhikuhi ʻia e like me ke adjuvant i loko o ka maʻi paʻakikī i ka mālama ʻana i ke ʻano o ka mellitus non-insulin-depend. Loaʻa i ka ʻano o kahi hoʻonā no ka injutaneous injection. ʻO ka mea hana nui ka exenatide. ʻO ka kumukūʻai kumu o ia lāʻau lapaʻau i nā lāʻau lapaʻau he 4 tausani mau rubles.
Eia kekahi, ʻo ka analogue o ka lāʻau Viktoza ka mea ʻo Luxumia
Hiki wale i ke kauka hele ke hoʻoholo i ka pono e hoʻololi i ka lāʻau lapaʻau i ka wā o ka papa lāʻau.
ʻO ke wikiō ma kēia ʻatikala e kamaʻilio e pili ana i nā lāʻau lapaʻau e hoʻohaʻahaʻa i ke kōpaʻa koko.
